Connection

Co-Authors

This is a "connection" page, showing publications co-authored by TIMOTHY J MCDONNELL and L JEFFREY MEDEIROS.
Connection Strength

1.591
  1. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia. 2023 02; 37(2):422-432.
    View in: PubMed
    Score: 0.217
  2. Interaction between the TP63 and SHH pathways is an important determinant of epidermal homeostasis. Cell Death Differ. 2013 Aug; 20(8):1080-8.
    View in: PubMed
    Score: 0.112
  3. Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features. Leukemia. 2010 Apr; 24(4):740-7.
    View in: PubMed
    Score: 0.089
  4. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death. Apoptosis. 2009 Apr; 14(4):336-47.
    View in: PubMed
    Score: 0.084
  5. Dicarbonyl/L-xylulose reductase: a potential biomarker identified by laser-capture microdissection-micro serial analysis of gene expression of human prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2615-22.
    View in: PubMed
    Score: 0.077
  6. Combined laser capture microdissection and serial analysis of gene expression from human tissue samples. Mod Pathol. 2005 Apr; 18(4):577-84.
    View in: PubMed
    Score: 0.064
  7. MCL-1 expression in B-cell non-Hodgkin's lymphomas. Hum Pathol. 2004 Sep; 35(9):1095-100.
    View in: PubMed
    Score: 0.061
  8. Caspase-3 activation in systemic anaplastic large-cell lymphoma. Mod Pathol. 2004 Jan; 17(1):109-16.
    View in: PubMed
    Score: 0.058
  9. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation. J Pathol. 2003 Jun; 200(2):240-8.
    View in: PubMed
    Score: 0.056
  10. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res. 2003 Mar; 9(3):1121-8.
    View in: PubMed
    Score: 0.055
  11. Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours. J Pathol. 2003 Jan; 199(1):84-9.
    View in: PubMed
    Score: 0.054
  12. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms. Hum Pathol. 2022 Dec; 130:47-57.
    View in: PubMed
    Score: 0.054
  13. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections. Am J Clin Pathol. 2002 Sep; 118(3):328-34.
    View in: PubMed
    Score: 0.053
  14. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica. 2022 09 01; 107(9):2232-2237.
    View in: PubMed
    Score: 0.053
  15. Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors. Am J Pathol. 2002 Jun; 160(6):2309-10.
    View in: PubMed
    Score: 0.052
  16. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage. Am J Pathol. 2001 Aug; 159(2):527-35.
    View in: PubMed
    Score: 0.049
  17. Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy. Am J Hematol. 2020 Oct; 95(10):1221-1223.
    View in: PubMed
    Score: 0.045
  18. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP?treated diffuse large B-cell lymphoma. Eur J Haematol. 2020 Apr; 104(4):336-343.
    View in: PubMed
    Score: 0.044
  19. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma. J Natl Compr Canc Netw. 2016 08; 14(8):939-44.
    View in: PubMed
    Score: 0.035
  20. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2015 Dec; 28(12):1555-73.
    View in: PubMed
    Score: 0.033
  21. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2014 Jul; 27(7):958-71.
    View in: PubMed
    Score: 0.029
  22. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5):629-33.
    View in: PubMed
    Score: 0.028
  23. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. Blood. 2012 Apr 19; 119(16):3668-83.
    View in: PubMed
    Score: 0.026
  24. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Mod Pathol. 2012 Feb; 25(2):237-45.
    View in: PubMed
    Score: 0.025
  25. HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis. Mod Pathol. 2010 Mar; 23(3):381-91.
    View in: PubMed
    Score: 0.022
  26. HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target. Mod Pathol. 2007 Jan; 20(1):54-62.
    View in: PubMed
    Score: 0.018
  27. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene. 2004 Jul 15; 23(32):5426-34.
    View in: PubMed
    Score: 0.015
  28. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene. 2003 Aug 21; 22(35):5399-407.
    View in: PubMed
    Score: 0.014
  29. Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med. 2003 Apr; 127(4):424-31.
    View in: PubMed
    Score: 0.014
  30. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression. J Pathol. 2003 Jan; 199(1):90-7.
    View in: PubMed
    Score: 0.014
  31. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. Blood. 2002 Dec 01; 100(12):3935-41.
    View in: PubMed
    Score: 0.014
  32. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res. 2002 Sep; 26(9):849-55.
    View in: PubMed
    Score: 0.013
  33. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome. Clin Cancer Res. 2002 Feb; 8(2):488-93.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.